← Eichor
Condition: Androgen Deprivation Therapy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Androgen Deprivation Therapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of P
Phase 2/Phase 3 · 1 location(s) · baotai Liang · NCT06861192SRT Versus SRT+ADT in Prostate Cancer
Phase 3 · 1 location(s) · Marco Lorenzo Bonu · NCT05019846Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
Phase 1/Phase 2 · 2 location(s) · Virginia Commonwealth University · NCT06237179Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Phase 2 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06330805ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NA · 3 location(s) · Indiana University · NCT05879913Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
Phase 4 · 1 location(s) · Hamilton Health Sciences Corporation · NCT06908694Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabol
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT07202247TherApeutics in Early ProState Cancer (TAPS02)
Phase 2 · 6 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT05191680Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Phase 3 · 57 location(s) · Canadian Cancer Trials Group · NCT06235697PRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confi
Phase N/A · 3 location(s) · Istituto Clinico Humanitas · NCT06949254Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
NA · 1 location(s) · State University of New York at Buffalo · NCT06172283Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT04734730Prehabilitation to Patients With Prostate Cancer
NA · 3 location(s) · Odense University Hospital · NCT07162987Training for Men Undergoing Androgen Deprivation Therapy.
NA · 1 location(s) · The Swedish School of Sport and Health Sciences · NCT06449664Androgen-responsive POSLUMA-guided Intra-prostatic Boost
Phase 2 · 4 location(s) · Martin T. King, MD, PhD · NCT07393867Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT05327465Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in
Phase N/A · 1 location(s) · Oncology Institute of Southern Switzerland · NCT04543799Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer
Phase 2 · 2 location(s) · baotai Liang · NCT06834321Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
Phase 3 · 9 location(s) · European Organisation for Research and Treatment of Cancer - · NCT05974774Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly S
NA · 1 location(s) · Roswell Park Cancer Institute · NCT03880422Akkermansia Muciniphilia and Metabolic Side Effects of ADT
EARLY_Phase 1 · 1 location(s) · Western University · NCT05802121Role of Race in Nutritional Approach in Men on ADT
NA · 2 location(s) · University of California, Los Angeles · NCT06682390An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · 147 location(s) · Novartis Pharmaceuticals · NCT05939414Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic
Phase 3 · 26 location(s) · Nick Beije · NCT07260435Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Phase 3 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05352178ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
Phase 2 · 1 location(s) · NYU Langone Health · NCT06397703Towards Optimal Treatment for High Risk Prostate Cancer
NA · 1 location(s) · Haaglanden Medical Centre · NCT06204341Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)
Phase 2 · 1 location(s) · German Oncology Center, Cyprus · NCT06582446Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Phase 1 · 1 location(s) · University of Oklahoma · NCT06130995Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
Phase 2 · 1 location(s) · University of Chicago · NCT05790213
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.